High-risk neuroblastoma, documented to occur in half of all patients, is typically associated with metastasis to the liver, bone or bone marrow, and aggressive features such as MYCN oncogene amplification, as well as an unfavorable prognosis [2]. The gene discussed is MYCN; the disease is neuroblastoma.